Prosthetic joint infection: diagnosis and management

References

• Love C, Marwin SE, Palestro CJ. Nuclear medicine and the infected joint replacement. Semin. Nucl. Med.39, 66–78 (2009).
   PubMed Web of Science ®Google Scholar
• Kurtz S, Ong K, Lau E et al. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J. Bone Joint Surg. Am.89, 780–785 (2007).
   PubMed Web of Science ®Google Scholar
• Zimmerli W, Trampuz A, Ochsner PE. Prosthetic-joint infections. N. Engl. J. Med.351, 1645–1654 (2004).
   PubMed Web of Science ®Google Scholar
• Berbari EF, Hanssen AD, Duffy MC et al. Risk factors for prosthetic joint infection, case-control study. Clin. Infect. Dis.27, 1247–1254 (1998).
   PubMed Web of Science ®Google Scholar
• Bongartz T, Halligan CS, Osmon DR et al. Incidence and risk factors of prosthetic joint infection after total hip or knee replacement in patients with rheumatoid arthritis. Arthritis Rheum.59, 1713–1720 (2008).
   PubMed Web of Science ®Google Scholar
• Murdoch DR, Roberts SA, Fowler JV Jr et al. Infection of orthopedic prostheses after Staphylococcus aureus bacteremia. Clin. Infect. Dis.32, 647–649 (2001).
   PubMed Web of Science ®Google Scholar
• Asensio A, Ramos A, Munez E et al. Preoperative low molecular weight heparin as venous thromboembolism prophylaxis in patients at risk for prosthetic infection after knee arthroplasty. Infect. Cont. Hosp. Epidemiol.26, 903–909 (2005).
   PubMed Web of Science ®Google Scholar
• Fisman DN, Reilly DT, Karchmer AW, Goldie SJ. Clinical effectiveness and cost–effectiveness of 2 management strategies for infected total hip arthroplasty in the elderly. Clin. Infect. Dis.32, 419–430 (2001).
   PubMed Web of Science ®Google Scholar
• Lentino JR. Prosthetic joint infections, bane of orthopedists, challenge for infectious disease specialists. Clin. Infect. Dis.36, 1157–1161 (2003).
   PubMed Web of Science ®Google Scholar
• Trampuz A, Hanssen AD, Osmon DR et al. Synovial fluid leukocyte count and differential for the diagnosis of prosthetic knee infection. Am. J. Med.117, 556–562 (2004).
   PubMed Web of Science ®Google Scholar
• Weil Y, Mattan Y, Liebergall M, Rahav G. Brucella prosthetic joint infection, a report of 3 cases and a review of the literature. Clin. Infect. Dis.36, e81–e86 (2003).
   PubMed Web of Science ®Google Scholar
• Phelan DM, Osmon DR, Keating MR, Hanssen AD. Delayed reimplantation arthroplasty for candidal prosthetic joint infection, a report of 4 cases and review of the literature. Clin. Infect. Dis.34, 930–938 (2002).
   PubMed Web of Science ®Google Scholar
• Eid AJ, Berbari EF, Sia IG et al. Prosthetic joint infection due to rapidly growing mycobacteria, report of 8 cases and review of the literature. Clin. Infect. Dis.45, 687–694 (2007).
   PubMed Web of Science ®Google Scholar
• Marculescu CE, Berbari EF, Cockerill FR 3rd, Osmon DR. Fungi, mycobacteria, zoonotic and other organisms in prosthetic joint infection. Clin. Orthop. Relat. Res.451, 64–72 (2006).
   PubMedGoogle Scholar
• Zaman R, Abbas M, Burd E. Late prosthetic hip joint infection with Actinomyces israelii in an intravenous drug user, case report and literature review. J. Clin. Microbiol.40, 4391–4392 (2002).
   PubMed Web of Science ®Google Scholar
• Berbari EF, Marculescu C, Sia I et al. Culture-negative prosthetic joint infection. Clin. Infect. Dis.45, 1113–1119 (2007).
   PubMed Web of Science ®Google Scholar
• Darouiche RO. Device-associated infections, a macroproblem that starts with microadherence. Clin. Infect. Dis.33, 1567–1572 (2001).
   PubMed Web of Science ®Google Scholar
• Zimmerli W, Waldvogel FA, Vaudaux P, Nydegger UE. Pathogenesis of foreign body infection, description and characteristics of an animal model. J. Infect. Dis.146, 487–497 (1982).
   PubMed Web of Science ®Google Scholar
• Ceri H, Olson ME, Stremick C et al. The Calgary biofilm device, new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. J. Clin. Microbiol.37, 1771–1776 (1999).
   PubMed Web of Science ®Google Scholar
• del Pozo JL, Patel R. The challenge of treating biofilm-associated bacterial infections. Clin. Pharmacol. Ther.82, 204–209 (2007).
   PubMed Web of Science ®Google Scholar
• Isiklar ZU, Darouiche RO, Landon GC, Beck T. Efficacy of antibiotics alone for orthopaedic device related infections. Clin. Orthop. Relat. Res.332, 184–189 (1996).
   Google Scholar
• Tsukayama DT, Goldberg VM, Kyle R. Diagnosis and management of infection after total knee arthroplasty. J. Bone Joint Surg. Am.85-A(Suppl. 1), S75–S80 (2003).
   Google Scholar
• Ariza J, Euba G, Murillo O. Orthopedic device-related infections. Enferm. Infect. Microbiol. Clin.26, 380–390 (2008).
   PubMed Web of Science ®Google Scholar
• Hanssen AD, Rand JA. Evaluation and treatment of infection at the site of a total hip or knee arthroplasty. Instr. Course Lect.48, 111–122 (1999).
   PubMedGoogle Scholar
• Tsukayama DT, Estrada R, Gustilo RB. Infection after total hip arthroplasty. A study of the treatment of one hundred and six infections. J. Bone Joint Surg. Am.78, 512–523 (1996).
   PubMed Web of Science ®Google Scholar
• del Pozo JL, Patel R, Clinical practice. Infection associated with prosthetic joints. N. Engl. J. Med.361, 787–794 (2009).
   PubMed Web of Science ®Google Scholar
• Tattevin P, Cremieux AC, Pottier P et al. Prosthetic joint infection, when can prosthesis salvage be considered? Clin. Infect. Dis.29, 292–295 (1999).
   PubMed Web of Science ®Google Scholar
• Atkins BL, Athanasou N, Deeks JJ et al. Prospective evaluation of criteria for microbiological diagnosis of prosthetic-joint infection at revision arthroplasty. The OSIRIS collaborative study group. J. Clin. Microbiol.36, 2932–2939 (1998).
   PubMed Web of Science ®Google Scholar
• Trampuz A, Widmer AF. Infections associated with orthopedic implants. Curr. Opin. Infect. Dis.19, 349–356 (2006).
   PubMed Web of Science ®Google Scholar
• Tunney MM, Dunne N, Einarsson G et al. Biofilm formation by bacteria isolated from retrieved failed prosthetic hip implants in an in vitro model of hip arthroplasty antibiotic prophylaxis. J. Orthop. Res.25, 2–10 (2007).
   PubMed Web of Science ®Google Scholar
• Della VC, Parvizi J, Bauer TW et al. Diagnosis of periprosthetic joint infections of the hip and knee. J. Am. Acad. Orthop. Surg.18, 760–770 (2010).
   PubMed Web of Science ®Google Scholar
• Athanasou NA, Pandey R, de Steiger R et al. Diagnosis of infection by frozen section during revision arthroplasty. J. Bone Joint Surg. Br.77, 28–33 (1995).
   PubMedGoogle Scholar
• Schinsky MF, la Valle CJ, Sporer SM, Paprosky WG. Perioperative testing for joint infection in patients undergoing revision total hip arthroplasty. J. Bone Joint Surg. Am.90, 1869–1875 (2008).
   PubMed Web of Science ®Google Scholar
• Spangehl MJ, Masri BA, O’Connell JX, Duncan CP. Prospective analysis of preoperative and intraoperative investigations for the diagnosis of infection at the sites of two hundred and two revision total hip arthroplasties. J. Bone Joint Surg. Am.81, 672–683 (1999).
   PubMed Web of Science ®Google Scholar
• Pandey R, Berendt AR, Athanasou NA. Histological and microbiological findings in non-infected and infected revision arthroplasty tissues. The OSIRIS collaborative study group. Oxford skeletal infection research and intervention service. Arch. Orthop. Trauma Surg.120, 570–574 (2000).
   PubMed Web of Science ®Google Scholar
• Trampuz A, Zimmerli W. Antimicrobial agents in orthopaedic surgery, prophylaxis and treatment. Drugs66, 1089–1105 (2006).
   PubMed Web of Science ®Google Scholar
• Schafer P, Fink B, Sandow D et al. Prolonged bacterial culture to identify late periprosthetic joint infection, a promising strategy. Clin. Infect. Dis.47, 1403–1409 (2008).
   PubMed Web of Science ®Google Scholar
• Trampuz A, Zimmerli W. Diagnosis and treatment of infections associated with fracture-fixation devices. Injury37(Suppl. 2), S59–S66 (2006).
   PubMed Web of Science ®Google Scholar
• Trampuz A, Piper KE, Jacobson MJ et al. Sonication of removed hip and knee prostheses for diagnosis of infection. N. Engl. J. Med.357, 654–663 (2007).
   PubMed Web of Science ®Google Scholar
• Vandercam B, Jeumont S, Cornu O et al. Amplification-based DNA analysis in the diagnosis of prosthetic joint infection. J. Mol. Diagn.10, 537–543 (2008).
   PubMed Web of Science ®Google Scholar
• Tigges S, Stiles RG, Roberson JR. Complications of hip arthroplasty causing periprosthetic radiolucency on plain radiographs. Am. J. Roentgenol.162, 1387–1391 (1994).
   PubMed Web of Science ®Google Scholar
• Love C, Tomas MB, Marwin SE et al. Role of nuclear medicine in diagnosis of the infected joint replacement. Radiographics21, 1229–1238 (2001).
   PubMed Web of Science ®Google Scholar
• Kwee TC, Kwee RM, Alavi A. FDG-PET for diagnosing prosthetic joint infection, systematic review and metaanalysis. Eur. J. Nucl. Med. Mol. Imaging35, 2122–2132 (2008).
   PubMed Web of Science ®Google Scholar
• Pill SG, Parvizi J, Tang PH et al. Comparison of fluorodeoxyglucose positron emission tomography and (111)indium-white blood cell imaging in the diagnosis of periprosthetic infection of the hip. J. Arthropl.21, 91–97 (2006).
   PubMed Web of Science ®Google Scholar
• Van Acker F, Nuyts J, Maes A et al. FDG-PET, 99mTc-HMPAO white blood cell SPET and bone scintigraphy in the evaluation of painful total knee arthroplasties. Eur. J. Nucl. Med.28, 1496–1504 (2001).
   PubMedGoogle Scholar
• Pakos EE, Trikalinos TA, Fotopoulos AD, Ioannidis JP. Prosthesis infection, diagnosis after total joint arthroplasty with antigranulocyte scintigraphy with 99mTc-labeled monoclonal antibodies – a metaanalysis. Radiology242, 101–108 (2007).
   PubMed Web of Science ®Google Scholar
• Zimmerli W. Infection and musculoskeletal conditions. Prosthetic-joint-associated infections. Best Pract. Res. Clin. Rheumatol.20, 1045–1063 (2006).
   PubMed Web of Science ®Google Scholar
• Zimmerli W, Ochsner PE. Management of infection associated with prosthetic joints. Infection31, 99–108 (2003).
   PubMed Web of Science ®Google Scholar
• Langlais F, Belot N, Ropars M et al. Antibiotic cements in articular prostheses, current orthopaedic concepts. Int. J. Antimicrob. Agents28, 84–89 (2006).
   PubMed Web of Science ®Google Scholar
• Betsch BY, Eggli S, Siebenrock KA et al. Treatment of joint prosthesis infection in accordance with current recommendations improves outcome. Clin. Infect. Dis.46, 1221–1226 (2008).
   PubMed Web of Science ®Google Scholar
• Giulieri SG, Graber P, Ochsner PE, Zimmerli W. Management of infection associated with total hip arthroplasty according to a treatment algorithm. Infection32, 222–228 (2004).
   PubMed Web of Science ®Google Scholar
• Laffer RR, Graber P, Ochsner PE, Zimmerli W. Outcome of prosthetic knee-associated infection, evaluation of 40 consecutive episodes at a single centre. Clin. Microbiol. Infect.12, 433–439 (2006).
   PubMed Web of Science ®Google Scholar
• Vilchez F, Martinez-Pastor JC, Garcia-Ramiro S et al. Outcome and predictors of treatment failure in early post-surgical prosthetic joint infections due to Staphylococcus aureus treated with debridement. Clin. Microbiol. Infect.17(3), 439–444 (2011).
   PubMed Web of Science ®Google Scholar
• Berdal JE, Skramm I, Mowinckel P et al. Use of rifampicin and ciprofloxacin combination therapy after surgical debridement in the treatment of early manifestation prosthetic joint infections. Clin. Microbiol. Infect.11, 843–845 (2005).
   PubMed Web of Science ®Google Scholar
• Aboltins CA, Page MA, Buising KL et al. Treatment of staphylococcal prosthetic joint infections with debridement, prosthesis retention and oral rifampicin and fusidic acid. Clin. Microbiol. Infect.13, 586–591 (2007).
   PubMed Web of Science ®Google Scholar
• Cobo J, Miguel LG, Euba G et al. Early prosthetic joint infection, outcomes with debridement and implant retention followed by antibiotic therapy. Clin. Microbiol. Infect. DOI: 10.1111/j.1469-0691.2010.03333.x (2010) (Epub ahead of print).
   Google Scholar
• Mont MA, Waldman B, Banerjee C et al. Multiple irrigation, debridement, and retention of components in infected total knee arthroplasty. J. Arthroplasty12, 426–433 (1997).
   PubMed Web of Science ®Google Scholar
• Azzam KA, Seeley M, Ghanem E et al. Irrigation and debridement in the management of prosthetic joint infection, traditional indications revisited. J. Arthroplasty25(7), 1022–1027 (2010).
   PubMed Web of Science ®Google Scholar
• Deirmengian C, Greenbaum J, Lotke PA et al. Limited success with open debridement and retention of components in the treatment of acute Staphylococcus aureus infections after total knee arthroplasty. J. Arthroplasty18, 22–26 (2003).
   PubMed Web of Science ®Google Scholar
• Bradbury T, Fehring TK, Taunton M et al. The fate of acute methicillin-resistant Staphylococcus aureus periprosthetic knee infections treated by open debridement and retention of components. J. Arthroplasty24, 101–104 (2009).
   PubMed Web of Science ®Google Scholar
• Bernard L, Hoffmeyer P, Assal M et al. Trends in the treatment of orthopaedic prosthetic infections. J. Antimicrob. Chemother.53, 127–129 (2004).
   PubMed Web of Science ®Google Scholar
• Crockarell JR, Hanssen AD, Osmon DR, Morrey BF. Treatment of infection with debridement and retention of the components following hip arthroplasty. J. Bone Joint Surg. Am.80, 1306–1313 (1998).
   PubMed Web of Science ®Google Scholar
• Soriano A, Garcia S, Bori G et al. Treatment of acute post-surgical infection of joint arthroplasty. Clin. Microbiol. Infect.12, 930–933 (2006).
   PubMed Web of Science ®Google Scholar
• Rodriguez D, Pigrau C, Euba G et al. Acute hematogenous prosthetic joint infection, prospective evaluation of medical and surgical management. Clin. Microbiol. Infect. DOI: 10.1111/j.1469–0691.2009.03157.x (2009) (Epub ahead of print).
   PubMedGoogle Scholar
• Hirakawa K, Stulberg BN, Wilde AH et al. Results of 2-stage reimplantation for infected total knee arthroplasty. J. Arthroplasty13, 22–28 (1998).
   PubMed Web of Science ®Google Scholar
• Bejon P, Berendt A, Atkins BL et al. Two-stage revision for prosthetic joint infection, predictors of outcome and the role of reimplantation microbiology. J. Antimicrob. Chemother.65, 569–575 (2010).
   PubMed Web of Science ®Google Scholar
• Barrack RL, McClure JT, Burak CF et al. Revision total knee arthroplasty, the patient’s perspective. Clin. Orthop. Relat. Res.464, 146–150 (2007).
   PubMedGoogle Scholar
• Salgado CD, Dash S, Cantey JR, Marculescu CE. Higher risk of failure of methicillin-resistant Staphylococcus aureus prosthetic joint infections. Clin. Orthop. Relat. Res.461, 48–53 (2007).
   PubMed Web of Science ®Google Scholar
• El Helou OC, Berbari EF, Lahr BD et al. Efficacy and safety of rifampin containing regimen for staphylococcal prosthetic joint infections treated with debridement and retention. Eur. J. Clin. Microbiol. Infect. Dis.29, 961–967 (2010).
   PubMed Web of Science ®Google Scholar
• Dixon P, Parish EN, Cross MJ. Arthroscopic debridement in the treatment of the infected total knee replacement. J. Bone Joint Surg. Br.86, 39–42 (2004).
   PubMedGoogle Scholar
• Waldman BJ, Hostin E, Mont MA, Hungerford DS. Infected total knee arthroplasty treated by arthroscopic irrigation and debridement. J. Arthroplasty15, 430–436 (2000).
   PubMed Web of Science ®Google Scholar
• Byren I, Bejon P, Atkins BL et al. One hundred and twelve infected arthroplasties treated with ‘DAIR’ (debridement, antibiotics and implant retention), antibiotic duration and outcome. J. Antimicrob. Chemother.63, 1264–1271 (2009).
   PubMed Web of Science ®Google Scholar
• Pavoni GL, Giannella M, Falcone M et al. Conservative medical therapy of prosthetic joint infections, retrospective analysis of an 8-year experience. Clin. Microbiol. Infect.10, 831–837 (2004).
   PubMed Web of Science ®Google Scholar
• Burnett RS, Kelly MA, Hanssen AD, Barrack RL. Technique and timing of two-stage exchange for infection in TKA. Clin. Orthop. Relat. Res.464, 164–178 (2007).
   PubMedGoogle Scholar
• von Foerster G, Kluber D, Kabler U. Mid- to long-term results after treatment of 118 cases of periprosthetic infections after knee joint replacement using one-stage exchange surgery. Orthopade20, 244–252 (1991).
   PubMed Web of Science ®Google Scholar
• Jamsen E, Stogiannidis I, Malmivaara A et al. Outcome of prosthesis exchange for infected knee arthroplasty, the effect of treatment approach. Acta. Orthop.80, 67–77 (2009).
   PubMed Web of Science ®Google Scholar
• Langlais F. Can we improve the results of revision arthroplasty for infected total hip replacement? J. Bone Joint Surg. Br.85, 637–640 (2003).
   PubMed Web of Science ®Google Scholar
• Bargiotas K, Wohlrab D, Sewecke JJ et al. Arthrodesis of the knee with a long intramedullary nail following the failure of a total knee arthroplasty as the result of infection. Surgical technique. J. Bone Joint Surg. Am.89(Suppl. 2) Pt 1, 103–110 (2007).
   PubMedGoogle Scholar
• Zimmerli W, Widmer AF, Blatter M et al. Role of rifampin for treatment of orthopedic implant-related staphylococcal infections, a randomized controlled trial. Foreign-Body Infection (FBI) study group. JAMA279, 1537–1541 (1998).
   PubMed Web of Science ®Google Scholar
• Bernard L, Legout L, Zurcher-Pfund L et al. Six weeks of antibiotic treatment is sufficient following surgery for septic arthroplasty. J. Infect.61, 125–132 (2010).
   PubMed Web of Science ®Google Scholar
• Barberan J, Aguilar L, Carroquino G et al. Conservative treatment of staphylococcal prosthetic joint infections in elderly patients. Am. J. Med.119(11), 993 e7–e10 (2006).
   PubMed Web of Science ®Google Scholar
• Piso RJ, Elke R. Antibiotic treatment can be safely stopped in asymptomatic patients with prosthetic joint infections despite persistent elevated C-reactive protein values. Infection38, 293–296 (2010).
   PubMed Web of Science ®Google Scholar
• Widmer AF, Wiestner A, Frei R, Zimmerli W. Killing of nongrowing and adherent Escherichia coli determines drug efficacy in device-related infections. Antimicrob. Agents Chemother.35, 741–746 (1991).
   PubMed Web of Science ®Google Scholar
• Zimmerli W, Frei R, Widmer AF, Rajacic Z. Microbiological tests to predict treatment outcome in experimental device-related infections due to Staphylococcus aureus. J. Antimicrob. Chemother.33, 959–967 (1994).
   PubMed Web of Science ®Google Scholar
• Blaser J, Vergeres P, Widmer AF, Zimmerli W. In vivo verification of in vitro model of antibiotic treatment of device-related infection. Antimicrob. Agents Chemother.39, 1134–1139 (1995).
   PubMed Web of Science ®Google Scholar
• Widmer AF, Gaechter A, Ochsner PE, Zimmerli W. Antimicrobial treatment of orthopedic implant-related infections with rifampin combinations. Clin. Infect. Dis.14, 1251–1253 (1992).
   PubMed Web of Science ®Google Scholar
• Chuard C, Herrmann M, Vaudaux P et al. Successful therapy of experimental chronic foreign-body infection due to methicillin-resistant Staphylococcus aureus by antimicrobial combinations. Antimicrob. Agents Chemother.35, 2611–2616 (1991).
   PubMed Web of Science ®Google Scholar
• Kang SL, Rybak MJ, McGrath BJ et al. Pharmacodynamics of levofloxacin, ofloxacin, and ciprofloxacin, alone and in combination with rifampin, against methicillin-susceptible and -resistant Staphylococcus aureus in an in vitro infection model. Antimicrob. Agents Chemother.38, 2702–2709 (1994).
   PubMed Web of Science ®Google Scholar
• Murillo O, Domenech A, Garcia A et al. Efficacy of high doses of levofloxacin in experimental foreign-body infection by methicillin-susceptible Staphylococcus aureus. Antimicrob. Agents Chemother.50, 4011–4017 (2006).
   PubMed Web of Science ®Google Scholar
• Senneville E, Poissy J, Legout L et al. Safety of prolonged high-dose levofloxacin therapy for bone infections. J. Chemother.19, 688–693 (2007).
   PubMed Web of Science ®Google Scholar
• Lovering AM, Zhang J, Bannister GC et al. Penetration of linezolid into bone, fat, muscle and haematoma of patients undergoing routine hip replacement. J. Antimicrob. Chemother.50, 73–77 (2002).
   PubMed Web of Science ®Google Scholar
• Murillo O, Domenech A, Euba G et al. Efficacy of linezolid alone and in combination with rifampin in staphylococcal experimental foreign-body infection. J. Infect.57, 229–235 (2008).
   PubMed Web of Science ®Google Scholar
• Baldoni D, Haschke M, Rajacic Z et al. Linezolid alone or combined with rifampin against methicillin-resistant Staphylococcus aureus in experimental foreign-body infection. Antimicrob. Agents. Chemother.53, 1142–1148 (2009).
   PubMed Web of Science ®Google Scholar
• Aneziokoro CO, Cannon JP, Pachucki CT, Lentino JR. The effectiveness and safety of oral linezolid for the primary and secondary treatment of osteomyelitis. J. Chemother.17, 643–650 (2005).
   PubMed Web of Science ®Google Scholar
• Bassetti M, Righi E, Di Biagio A et al. Role of linezolid in the treatment of orthopedic infections. Expert. Rev. Anti. Infect. Ther.3, 343–352 (2005).
   PubMedGoogle Scholar
• Falagas ME, Siempos II, Papagelopoulos PJ, Vardakas KZ. Linezolid for the treatment of adults with bone and joint infections. Int. J. Antimicrob. Agents29, 233–239 (2007).
   PubMed Web of Science ®Google Scholar
• Rao N, Hamilton CW. Efficacy and safety of linezolid for Gram-positive orthopedic infections, a prospective case series. Diagn. Microbiol. Infect. Dis.59, 173–179 (2007).
   PubMed Web of Science ®Google Scholar
• Soriano A, Gomez J, Gomez L et al. Efficacy and tolerability of prolonged linezolid therapy in the treatment of orthopedic implant infections. Eur. J. Clin. Microbiol. Infect. Dis.26, 353–356 (2007).
   PubMed Web of Science ®Google Scholar
• Plachouras D, Giannitsioti E, Athanassia S et al. No effect of pyridoxine on the incidence of myelosuppression during prolonged linezolid treatment. Clin. Infect. Dis.43, e89–e91 (2006).
   PubMed Web of Science ®Google Scholar
• Rucker JC, Hamilton SR, Bardenstein D et al. Linezolid-associated toxic optic neuropathy. Neurology66, 595–598 (2006).
   PubMed Web of Science ®Google Scholar
• Mascio CT, Alder JD, Silverman JA. Bactericidal action of daptomycin against stationary-phase and nondividing Staphylococcus aureus cells. Antimicrob. Agents Chemother.51, 4255–4260 (2007).
   PubMed Web of Science ®Google Scholar
• Falagas ME, Giannopoulou KP, Ntziora F, Papagelopoulos PJ. Daptomycin for treatment of patients with bone and joint infections, a systematic review of the clinical evidence. Int. J. Antimicrob. Agents30, 202–209 (2007).
   PubMed Web of Science ®Google Scholar
• Stein A, Bataille JF, Drancourt M et al. Ambulatory treatment of multidrug-resistant staphylococcus-infected orthopedic implants with high-dose oral co-trimoxazole (trimethoprim-sulfamethoxazole). Antimicrob. Agents Chemother.42, 3086–3091 (1998).
   PubMed Web of Science ®Google Scholar
• Euba G, Murillo O, Fernandez-Sabe N et al. Long-term follow-up trial of oral rifampin-cotrimoxazole combination versus intravenous cloxacillin in treatment of chronic staphylococcal osteomyelitis. Antimicrob. Agents Chemother.53, 2672–2676 (2009).
   PubMed Web of Science ®Google Scholar
• Drancourt M, Stein A, Argenson JN et al. Oral treatment of Staphylococcus spp. infected orthopaedic implants with fusidic acid or ofloxacin in combination with rifampicin. J. Antimicrob. Chemother.39, 235–240 (1997).
   PubMed Web of Science ®Google Scholar
• Rao N, Crossett LS, Sinha RK, Le Frock JL. Long-term suppression of infection in total joint arthroplasty. Clin. Orthop. Relat. Res.414, 55–60 (2003).
   Google Scholar
• Segreti J, Nelson JA, Trenholme GM. Prolonged suppressive antibiotic therapy for infected orthopedic prostheses. Clin. Infect. Dis.27, 711–713 (1998).
   PubMed Web of Science ®Google Scholar
• Tsukayama DT, Wicklund B, Gustilo RB. Suppressive antibiotic therapy in chronic prosthetic joint infections. Orthopedics14, 841–844 (1991).
   PubMed Web of Science ®Google Scholar
• Marculescu CE, Berbari EF, Hanssen AD et al. Outcome of prosthetic joint infections treated with debridement and retention of components. Clin. Infect. Dis.42, 471–478 (2006).
   PubMed Web of Science ®Google Scholar
• van der Linden PD, Sturkenboom MC, Herings RM et al. Increased risk of achilles tendon rupture with quinolone antibacterial use, especially in elderly patients taking oral corticosteroids. Arch. Intern. Med.163, 1801–1807 (2003).
   PubMed Web of Science ®Google Scholar
• Whittaker JP, Warren RE, Jones RS, Gregson PA. Is prolonged systemic antibiotic treatment essential in two-stage revision hip replacement for chronic Gram-positive infection? J. Bone Joint Surg. Br.91, 44–51 (2009).
   PubMedGoogle Scholar
• Hoad-Reddick DA, Evans CR, Norman P, Stockley I. Is there a role for extended antibiotic therapy in a two-stage revision of the infected knee arthroplasty? J. Bone Joint Surg. Br.87, 171–174 (2005).
   PubMedGoogle Scholar
• Stockley I, Mockford BJ, Hoad-Reddick A, Norman P. The use of two-stage exchange arthroplasty with depot antibiotics in the absence of long-term antibiotic therapy in infected total hip replacement. J. Bone Joint Surg. Br.90, 145–148 (2008).
   PubMedGoogle Scholar
• McKenna PB, O’Shea K, Masterson EL.Two-stage revision of infected hip arthroplasty using a shortened post-operative course of antibiotics. Arch. Orthop. Trauma Surg.129, 489–494 (2009).
   PubMed Web of Science ®Google Scholar
• Mont MA, Waldman BJ, Hungerford DS. Evaluation of preoperative cultures before second-stage reimplantation of a total knee prosthesis complicated by infection. A comparison-group study. J. Bone Joint Surg. Am.82-A, 1552–1557 (2000).
   Google Scholar
• Ghanem E, Azzam K, Seeley M et al. Staged revision for knee arthroplasty infection, what is the role of serologic tests before reimplantation? Clin. Orthop. Relat. Res.467, 1699–1705 (2009).
   PubMed Web of Science ®Google Scholar
• Lonner JH, Siliski JM, Della VC et al. Role of knee aspiration after resection of the infected total knee arthroplasty. Am. J. Orthop (Belle Mead NJ)30, 305–309 (2001).
   PubMedGoogle Scholar
• Kendall RW, Duncan CP, Smith JA, Ngui-Yen JH. Persistence of bacteria on antibiotic loaded acrylic depots. A reason for caution. Clin. Orthop. Relat. Res.273–280 (1996).
   PubMedGoogle Scholar
• Murillo O, Euba G, Calatayud L et al. The role of intraoperative cultures at the time of reimplantation in the management of infected total joint arthroplasty. Eur. J. Clin. Microbiol. Infect. Dis.27, 805–811 (2008).
   PubMed Web of Science ®Google Scholar
• Anagnostakos K, Hitzler P, Pape D et al. Persistence of bacterial growth on antibiotic-loaded beads, is it actually a problem? Acta. Orthop.79, 302–307 (2008).
   PubMed Web of Science ®Google Scholar